During the past decade, Miami Center for Cardiovascular Disease conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Miami Center for Cardiovascular Disease" are "Atrial Fibrillation" (1 trials), "Pulmonary Arterial Hypertension" (1 trials) and "Stroke" (1 trials). Many other conditions were trialed in "Miami Center for Cardiovascular Disease" in a lesser frequency.

Most popular intervention types in "Miami Center for Cardiovascular Disease" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "inhaled prostacyclin" (1 trials), "oral ERA" (1 trials), "oral PDE5 inhibitors" (1 trials), "prostacyclin" (1 trials) and "subcutaneous and intravenous prostacyclin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Miami Center for Cardiovascular Disease" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Miami Center for Cardiovascular Disease". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Miami Center for Cardiovascular Disease, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Miami Center for Cardiovascular Disease, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".